1. Home
  2. ENVX vs CDNA Comparison

ENVX vs CDNA Comparison

Compare ENVX & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enovix Corporation

ENVX

Enovix Corporation

HOLD

Current Price

$7.06

Market Cap

1.1B

Sector

Miscellaneous

ML Signal

HOLD

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$20.67

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENVX
CDNA
Founded
2006
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical Specialities
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
2020
2007

Fundamental Metrics

Financial Performance
Metric
ENVX
CDNA
Price
$7.06
$20.67
Analyst Decision
Buy
Buy
Analyst Count
9
6
Target Price
$13.61
$27.60
AVG Volume (30 Days)
5.6M
704.2K
Earning Date
05-06-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
40.94
N/A
EPS
N/A
N/A
Revenue
$31,821,000.00
$48,324,000.00
Revenue This Year
$30.37
$16.01
Revenue Next Year
$238.73
$11.31
P/E Ratio
N/A
N/A
Revenue Growth
37.91
18.93
52 Week Low
$4.67
$10.96
52 Week High
$16.49
$23.24

Technical Indicators

Market Signals
Indicator
ENVX
CDNA
Relative Strength Index (RSI) 67.70 61.03
Support Level $6.68 $16.63
Resistance Level $8.66 $21.20
Average True Range (ATR) 0.40 1.26
MACD 0.15 0.46
Stochastic Oscillator 99.13 66.54

Price Performance

Historical Comparison
ENVX
CDNA

About ENVX Enovix Corporation

Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, the United States, Norway, Taiwan, and other regions.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: